Asaf Zviran: Next generation AI-powered spectral proteomics is coming… Vionix Biosciences! 

Asaf Zviran, Co-Founder and CTO of Vionix Biosciences, recently shared on LinkedIn:

“Coming out of stealth!
Next Generation Sequencing (NGS) has transformed medicine and increased our understanding of human diseases. However, there is a growing need for: rapid (<1h), cheap (<$50) and point-of-care diagnostic solutions. Coupled with comprehensive proteomics / metabolomics characterization. With clinical applications spanning from infectious diseases (e.g., tuberculosis) to cancer screening and aging, using a simple breath or urine test.
Next generation AI-powered spectral proteomics is coming… Vionix Biosciences!
Check out our recent coverage at Bloomberg.
Stay tuned for more news…”

For details click here.
Source: Asaf Zviran/LinkedIn